Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Description:** 7-ketodehydroepiandrosterone (commonly known as "7-keto-DHEA" or "7-Keto") is a naturally occurring metabolite of the steroid hormone dehydroepiandrosterone (DHEA). Unlike DHEA, it is not converted to sex hormones such as androgens or estrogens in the body. It has been marketed primarily as a dietary supplement for weight loss and metabolic support. The proposed mechanism involves increasing thermogenesis by activating thermogenic enzymes, thereby potentially raising resting metabolic rate and promoting fat utilization for energy. However, clinical evidence supporting these claims remains limited and inconclusive; most studies are small or short-term[1][2][5]. The compound is generally well-tolerated but long-term safety data are lacking. It is not approved by the FDA as a pharmaceutical drug[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 7-ketodehydroepiandrosterone.